Boston University
Left ventricular hypertrophy and its regression utilizing antihypertensive drugs
Abstract
dc:description.abstractLeft ventricular hypertrophy (LVH) is an adaptational response to an increased pressure load on the heart imposed by systemic hypertension. Increased myocardial muscle mass reduces left ventricular wall stress as predicted by the LaPlace equation. Therefore, the hypertrophied ventrical can generate increased pressure, with normal wall stress, in order to maintain normal cardiac output. However, LVH is associated with both an increased risk of heart failure, as well as other forms of morbidity, and of mortality. Regression of LVH by some antihypertensive agents can be achieved for reasons not related to their effect on peripheral blood pressure; although, reduction in blood pressure is also necessary. To date, LVH reversal, in addition to lowering of blood pressure, is a desirable therapeutic goal. Angiotensin converting enzyme inhibitors are most effective in reversing LVH and, therefore, should be considered for first-line therapy.
Degree
thesis:*- Name thesis:degree_name
- Master of Arts
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Pharmacology
- Grantor dc:publisher
- Boston University
- Year dc:date.issued
- 1988
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Katz, Marshall S
Rights
dc:rights- Statement dc:rights
-
- PLEASE NOTE: Boston University Libraries did not receive an Authorization To Manage form for this thesis or dissertation. It is therefore not openly accessible, though it may be available by request. If you are the author or principal advisor of this work and would like to request open access for it, please contact us at open-help@bu.edu. Thank you.
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Dc Identifier Barcode
- 11719015069141
- Dc Identifier Bibid
- 99187621100001161
- Dc Identifier Other
- b18376575